Abstract:OBJECTIVE:To detect the Th1 and Th2 cell percentage in pleural effusion mononuclear cells (PEMCs) stimulated by early secretory antigenic target protein-6 (ESAT-6)/culture filtrate protein-10 (CFP-10) fusion protein (E/C) with flow cytometry (FCM), and therefore to explore the local antigen specific Th1 and Th2 response and its diagnostic value in tuberculous pleuritis. METHODS:Forty patients with tuberculous pleural effusion and 30 patients with malignant pleural effusion were included in this study from Sep.2008 to Mar.2009. PEMCs were isolated and cryopreserved. After resuscitation, the cells were cultured with E/C (simultaneously with positive control and negative control), and antigen-specific Th1 and Th2 cells were detected with intracellular cytokine staining of FCM. Normal distribution data using t test, abnormal distribution data using Wilcoxon test. RESULTS:In the TB group,the medians (quartile range) of Th1 cells and Th1/Th2 ratio among PEMCs stimulated by ESAT-6/CFP-10 fusion protein were 3.06% (1.59%-6.92%) and 17 (7.38-35.53), significantly higher than those of the negative control [0.38% (0.02%-1.80%) and 3.59 (0.49-25.09)], the differences being statistically significant (Z = -5.345 and 3.314, P < 0.01). The percentage of Th2 cells [(0.22 ± 0.19)%] was also increased compared with that of the negative control [(0.10 ± 0.08)%], the difference being statistically significant (t = 4.108, P < 0.01). In the malignant effusion group, the medians (quartile range) of Th1 percentage and Th1/Th2 ratio were 0.12% (0.05%-0.39%) and 1.05 (0.25-2.52), which were significantly different as compared with those of the TB group (Z = -6.624 and -5.536, P < 0.01). The Th2 percentage in the 2 groups were (0.22 ± 0.19)% and (0.15 ± 0.02)%, respectively (t = 1.954, P > 0.05). The receiver operating characteristic curve indicated that the area under the curve (AUC), sensitivity, and specificity were 0.937, 85.4%, and 90.6% respectively for Th1 to diagnose tuberculous pleurisy. For Th1/Th2, the AUC, sensitivity, and specificity were 0.883, 81.5%, and 90.6% respectively. CONCLUSIONS:The feature of ESAT-6/CFP-10 fusion protein-specific Th1 and Th2 response in tuberculous pleurisy was a mixed reaction of Th1 and Th2 with Th1 predominance. Th1 percentage and Th1/Th2 ratio could be diagnostic indexes for identifying tuberculous from malignant pleural effusions.

The diagnostic value of tumor M2 pyruvate kinase in malignant pleural effusion

Significance of serum and pleural effusion levels of related factors in differential diagnosis of tuberculosis and malignant tumor

Diagnostic value of combined determination of mdikine with CEA level in differentiating malignant pleural effusion from tuberculous pleural effusion

Value of the Early Diagnosis of Polymerase Chain Reaction for Exudative Tuberculous Pleurisy

The Diagnostic Value of MCP-1 and RANTES in Tuberculosis and Malignant Pleural Effusion

Use of tumor markers in distinguishing lung adenocarcinoma-associated malignant pleural effusion from tuberculous pleural effusion

Combined Detection of Carcinoembryonic Antigen and C-reactive Protein in Identifying Benign and Malignant Pleural Effusion

Expressions and diagnostic value of the cytokines in tuberculous and malignant pleural effusion

The Diagnostic and Prognostic Value of the Combination of Tumor M2-Pyruvate Kinase, Carcinoembryonic Antigen, and Cytokeratin 19 Fragment in Non-Small Cell Lung Cancer

Auxiliary diagnostic value of tumor biomarkers in pleural fluid for lung cancer-associated malignant pleural effusion

Diagnostic Accuracy of Cancer in Pleural Effusion: A Combination Serum Tumor Markers and Cytology

Potential diagnostic value of serum/pleural fluid IL-31 levels for tuberculous pleural effusion

[Early Secretory Antigenic Target Protein-6/Culture Filtrate Protein-10 Fusion Protein-Specific Th1 and Th2 Response and Its Diagnostic Value in Tuberculous Pleural Effusion].

The expression levels of VEGF and ICAM-1 in pleural effusion

Diagnostic Accuracy of Tumour Markers for Malignant Pleural Effusion: a Meta-Analysis

The Diagnostic Significance of the Detection of Cytokeratin 19 Mrna by Quantitative RT-PCR in Benign and Malignant Pleural Effusions

Detection of Telomerase Activity in Pleural Effusion Cells from Patients with Malignant Neoplasm

Value of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 in Diagnosis and Differential Diagnosis of Pleural Effusion

Application of Three Tumor Markers United Detection in Differentiating Benign and Malignant Pleural Effusion

Clinical Significance of Combined Detection of CEA, CYFRA21-1,CA19-9 and Fer in Differential Diagnosis of Benign Pleural Effusion and Malignant Pleural Effusion

A Combination Of The Quantiferon-Tb Gold In-Tube Assay And The Detection Of Adenosine Deaminase Improves The Diagnosis Of Tuberculous Pleural Effusion